Schizophrenia & Other Psychotic Disorders
Savvy Psychopharmacology
Opiates and psychotropics: Pharmacokinetics for practitioners
Commentary
Comments & Controversies
News
DSM-5 Might Get Fewer Personality Disorders
News
New-Onset Psychosis Linked to Use of Fake Pot
Major Finding: Seven patients recovered from synthetic marijuana–induced psychosis within 8 days; three others still have symptoms after 5 months...
Evidence-Based Reviews
Minimizing the impact of elevated prolactin in children and adolescents
Early identification, treatment can help lessen impaired development, other sequelae
Evidence-Based Reviews
Does your patient have a psychiatric illness or nonverbal learning disorder?
Clinical clues help differentiate overlapping symptoms and syndromes
Savvy Psychopharmacology
Abuse of second-generation antipsychotics: What prescribers need to know
News
Depression in Elders With Schizophrenia May Moderate
News
Citalopram Reduces Suicidal Ideation, Depression in Schizophrenia
Major Finding: The selective serotonin reuptake inhibitor citalopram is effective for reducing depressive symptoms and suicidal ideation in older...
News
Theta Burst Stimulation Promising for Refractory Schizophrenia
Evidence-Based Reviews
Glutamate: New hope for schizophrenia treatment
Research on glutamatergic dyfunction may lead to therapies targeting negative and cognitive symptoms